Comparable to cancer in prevalence and costs, rheumatology diseases (autoimmune, musculoskeletal, inflammatory), are the next big chronic disease target. While health plans increasingly target chronic disease care: diabetes, hypertension, cancer and mental health—they often overlook a large group of costly chronic disorders. Rheumatic diseases cause...
Whether you manage payer, payvider, Medicare Advantage or employer healthcare plans, high-risk, high-cost chronic autoimmune conditions hide in your population. They may be called inflammatory, immuno-inflammatory or immune-mediated inflammatory disorders (IMIDs). Some are familiar: Rheumatoid arthritis (RA), Crohn’s disease, multiple sclerosis (MS); others are rare....
The Alliance of Community Health Plans (ACHP) launched a project exploring the role of health plans in influencing physician behavior and how health plans can partner with practices to adopt evidence-based practices at the point of care to improve outcomes. It was funded partially by...
The AMA’s model bill, the “Ensuring Transparency in Prior Authorization Act,” is designed to make the PA process timelier and less opaque. The CrossBridge solution helps connect rheumatologists and health plans to alleviate the administrative burden. It helps physicians select a treatment option to obtain...
New Report Examines Access, Affordability and Lifestyle Factors Affecting Rheumatic Disease Care in all 50 States and the District of Columbia The American College of Rheumatology (ACR) today released the Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America, a first-of-its-kind report that...